Inventor
Michael G. Yang
Inventor
Wilmington, DE, US
Overview
Patents· 38 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes15%
C07CAcyclic or carbocyclic compounds7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07KPeptides6%
C07BGeneral methods of organic chemistry5%
C04BLime, magnesia2%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
10,781,215Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFNa responses202010,709,719Substituted bicyclic compounds202010,633,339Tricyclic sulfone compound as a ROR gamma modulator202010,435,369Tricyclic sulfones as ROR gamma modulators201910,294,256Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of IL-12, IL-23 and/or IFN alpha responses201910,166,249Substituted bicyclic compounds20199,796,720'Imidazole-derived modulators of the glucocorticoid receptor'20179,770,459'Substituted bicyclic compounds'20179,593,113'Imide and acylurea derivatives as modulators of the glucocorticoid receptor'20179,522,888'Substituted bicyclic compounds'20167,829,571'Cyclic derivatives as modulators of chemokine receptor activity'20107,687,508'Cyclic derivatives as modulators of chemokine receptor activity'20107,671,062'Modulators of chemokine receptor activity, crystalline forms and process'20107,655,647'Substituted lactams as inhibitors of Aβ protein production'20107,629,351'N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and process'20097,528,249'Cyclic malonamides as inhibitors of aβ protein production'20097,498,324'Substituted lactams as inhibitors of Aβ protein production'20097,482,335'Cyclic derivatives as modulators of chemokine receptor activity'20097,390,896'Cyclic malonamides as inhibitors of Aβ protein production'20087,390,802'Substituted lactams as inhibitors of Aβ protein production'20087,378,409'Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity'20087,276,496'Cyclic malonamides as inhibitors of Aβ protein protection'20077,276,495'Substituted lactams as inhibitors of Aβ protein production'2007RE039680'Substituted heterocycle fused gamma-carbolines'2007RE039679'Substituted heterocycle fused gamma-carbolines'20077,183,282'Substituted heterocycle fused γ-carbolines'20077,163,937'Cyclic derivatives as modulators of chemokine receptor activity'20077,071,186'Substituted heterocycle fused gamma-carbolines'20067,053,081'Cyclic malonamides as inhibitors of A-β protein production'20067,001,901'Tetrazolylpropionamides as inhibitors of Aβ protein production'20066,900,199'Substituted lactams as inhibitors of Aβ protein production'20056,759,404'Cyclic malonamides as inhibitors of a protein production'20046,713,476'Substituted cycloalkyls as inhibitors of a beta protein production'20046,632,812'Substituted lactams as inhibitors of A protein production'20036,576,766'Signal transduction inhibitors, compositions containing them'20036,573,295'Bicyclic signal transduction inhibitors, compositions containing them & uses thereof'20036,552,017'Substituted heterocycle fused gamma-carbolines'20036,482,852'Bicyclic signal transduction inhibitors, compositions containing them & uses thereof'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2003Patents assigned to ARIAD PHARMA INC (3)· patent assignee history
2002–2003Based in Chestnut Hill, MA, US· patent location history
2003–2010Patents assigned to BRISTOL MYERS SQUIBB PHARMA CO (14)· patent assignee history
2003–2004Patents assigned to DU PONT PHARM CO (2)· patent assignee history
2003–2010Based in Wilmington, DE, US· patent location history
2006–2020Patents assigned to BRISTOL MYERS SQUIBB CO (18)· patent assignee history
2006–2020Based in Narberth, PA, US· patent location history
2009–2020Based in Narbeth, PA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 18 | 2006–2020 |
| BRISTOL MYERS SQUIBB PHARMA CO | 14 | 2003–2010 |
| ARIAD PHARMA INC | 3 | 2002–2003 |
| DU PONT PHARM CO | 2 | 2003–2004 |
Locations
| Location | Patents | Span |
|---|---|---|
| Wilmington, Delaware, US | 16 | 2003–2010 |
| Narbeth, Pennsylvania, US | 12 | 2009–2020 |
| Narberth, Pennsylvania, US | 8 | 2006–2020 |
| Chestnut Hill, Massachusetts, US | 2 | 2002–2003 |